Pradeep Jayarajan

664 total citations
56 papers, 521 citations indexed

About

Pradeep Jayarajan is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pradeep Jayarajan has authored 56 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 19 papers in Molecular Biology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pradeep Jayarajan's work include Cholinesterase and Neurodegenerative Diseases (20 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroscience and Neuropharmacology Research (9 papers). Pradeep Jayarajan is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (20 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroscience and Neuropharmacology Research (9 papers). Pradeep Jayarajan collaborates with scholars based in India, United States and United Kingdom. Pradeep Jayarajan's co-authors include Ramakrishna Nirogi, Renny Abraham, Anil Shinde, Vijay Benade, Gopinadh Bhyrapuneni, Vinod Goyal, Ramkumar Subramanian, Veera Raghava Chowdary Palacharla, Nageswararao Muddana and Vishwottam Kandikere and has published in prestigious journals such as Neurology, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Pradeep Jayarajan

52 papers receiving 507 citations

Peers

Countries citing papers authored by Pradeep Jayarajan

Since Specialization

Citations

This map shows the geographic impact of Pradeep Jayarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pradeep Jayarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pradeep Jayarajan more than expected).

Fields of papers citing papers by Pradeep Jayarajan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pradeep Jayarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pradeep Jayarajan. The network helps show where Pradeep Jayarajan may publish in the future.

Co-authorship network of co-authors of Pradeep Jayarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Pradeep Jayarajan. A scholar is included among the top collaborators of Pradeep Jayarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pradeep Jayarajan. Pradeep Jayarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resveratrol, a calorie restriction mimetic, protects AlCl3-induced neurotoxicity and cognitive deficits in rats via inhibition of oxidative stress 2025 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Vijay Benade, Pradeep Jayarajan, Krishnadas Nandakumar, Ramakrishna Nirogi	0
2	Samelisant (SUVN-G3031) - Topline Results from the Phase-2 Proof-of-Concept Double-blind, Placebo-controlled Study in Patients with Narcolepsy (P10-9.002) 2024 ·Neurology ·Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, Vinod Goyal, Anil Shinde, (unknown), (unknown), (unknown)	1
3	Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy 2024 ·Sleep Medicine ·Ramakrishna Nirogi, Anil Shinde, Vinod Goyal, (unknown), Vijay Benade, (unknown), (unknown), Ramkumar Subramanian, Veera Raghava Chowdary Palacharla, (unknown), Renny Abraham, (unknown), (unknown), Pradeep Jayarajan, (unknown), Richard Bogan	1
4	Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders 2023 ·Biomolecules ·Ramakrishna Nirogi, Pradeep Jayarajan, Anil Shinde, (unknown), (unknown), Vijay Benade, Vinod Goyal, Renny Abraham, (unknown), Jeffrey L. Cummings	31
5	0609 Samelisant, Histamine 3 Receptor Agonist for the Potential Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy 2023 ·SLEEP ·Ramakrishna Nirogi, (unknown), Pradeep Jayarajan, Vinod Goyal, (unknown), Anil Shinde, Vijay Benade	3
6	Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer's disease: Behavioural, neurochemical and pharmacological profiling 2023 ·European Journal of Pharmacology ·Ramakrishna Nirogi, (unknown), (unknown), (unknown), Renny Abraham, (unknown), Veera Raghava Chowdary Palacharla, (unknown), (unknown), Ramkumar Subramanian, (unknown), (unknown), Vijay Benade, Pradeep Jayarajan, (unknown)	3
7	Masupirdine (SUVN‐502) for the Potential Treatment of Agitation in Patients with Dementia of the Alzheimer’s Type: Preliminary Efficacy and Phase‐3 Study Design 2023 ·Alzheimer s & Dementia ·Ramakrishna Nirogi, Renny Abraham, (unknown), (unknown), Vijay Benade, Anil Shinde, Mohammed Abdul Rasheed, (unknown), Vinod Goyal, Veera Raghava Chowdary Palacharla, Ramkumar Subramanian, Pradeep Jayarajan	0
8	Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization 2022 ·Psychopharmacology ·Ramakrishna Nirogi, Renny Abraham, Pradeep Jayarajan, (unknown), (unknown), (unknown), (unknown), Vinod Goyal, (unknown), Ramkumar Subramanian, (unknown), (unknown), Veera Raghava Chowdary Palacharla, (unknown), (unknown), (unknown)	5
9	Potential benefits of Masupirdine (SUVN-502) on Behavioral and Psychological symptoms in patients with moderate Alzheimer’s Disease (5090) 2020 ·Neurology ·Ramakrishna Nirogi, Anil Shinde, Pradeep Jayarajan, Vinod Goyal, (unknown), Ramkumar Subramanian, (unknown), (unknown), (unknown)	3
10	SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization 2018 ·Behavioural Pharmacology ·Ramakrishna Nirogi, Renny Abraham, Vijay Benade, (unknown), Pradeep Jayarajan, Gopinadh Bhyrapuneni, Nageswararao Muddana, (unknown), Ramkumar Subramanian, Anil Shinde, (unknown), (unknown)	30
11	Simultaneous monitoring of electroencephalographic characteristics in animals subjected to behavioral tests: a preclinical investigation 2017 ·Behavioural Pharmacology ·Ramakrishna Nirogi, (unknown), Vijay Benade, (unknown), Gopinadh Bhyrapuneni, Pradeep Jayarajan	4
12	Chronic treatment with a selective 5-HT6 receptor antagonist alters the behavioral and neurochemical effects of ethanol in young adult rats 2015 ·Behavioural Pharmacology ·Pradeep Jayarajan, Ramakrishna Nirogi, Anil Shinde, Vijay Benade, (unknown)	1
13	Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease 2015 ·European Journal of Medicinal Chemistry ·Ramakrishna Nirogi, (unknown), Anil Shinde, (unknown), (unknown), (unknown), (unknown), Gopinadh Bhyrapuneni, (unknown), Vijay Benade, Veera Raghava Chowdary Palacharla, Pradeep Jayarajan, Ramkumar Subramanian, Vinod Goyal	46
14	Effect of olanzapine on scopolamine induced deficits in differential reinforcement of low rate 72 s (DRL-72 s) schedule in rats: Involvement of the serotonergic receptors in restoring the deficits 2013 ·European Journal of Pharmacology ·Pradeep Jayarajan, Ramakrishna Nirogi, Anil Shinde	5
15	α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain 2013 ·European Journal of Pharmacology ·Ramakrishna Nirogi, (unknown), Renny Abraham, Pradeep Jayarajan	29
16	Aripiprazole in an Animal Model of Chronic Alcohol Consumption and Dopamine D₂Receptor Occupancy in Rats 2013 ·The American Journal of Drug and Alcohol Abuse ·Ramakrishna Nirogi, Vishwottam Kandikere, Pradeep Jayarajan, Gopinadh Bhyrapuneni, Ramanatha Saralaya, Nageswararao Muddana, Renny Abraham	11
17	Comparison of manual and automated filaments for evaluation of neuropathic pain behavior in rats 2012 ·Journal of Pharmacological and Toxicological Methods ·Ramakrishna Nirogi, (unknown), (unknown), Pradeep Jayarajan, Renny Abraham	45
18	Difference in the norepinephrine levels of experimental and non-experimental rats with age in the object recognition task 2012 ·Brain Research ·Ramakrishna Nirogi, Renny Abraham, Pradeep Jayarajan, (unknown), (unknown), Vishwottam Kandikere, (unknown), Ramanatha Saralaya, Vijay Benade, Gopinadh Bhyrapuneni, Nageswararao Muddana	15
19	N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·Ramakrishna Nirogi, (unknown), (unknown), Anil Shinde, (unknown), (unknown), (unknown), Pradeep Jayarajan, Vishwottam Kandikere, P. K. Dubey	12
20	Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain 2011 ·European Journal of Pharmacology ·Ramakrishna Nirogi, Pradeep Jayarajan, Renny Abraham, (unknown), Mohammed Abdul Rasheed, (unknown), (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact